ActiCIDP is a monocentric academic study. Patients with Chronic inflammatory demyelinating polyradiculoneuritis may be included on a voluntary basis.
The investigators plan to include a group of approximately 40 patients with CIDP.
The investigators have planned to assess patient every three months for a year. After each visit, participants will wear Actimyo for one month daily.
Diagnosed with CIDP or possible CIDP based on 2021 EAN/PNS criteria2.
Treated with IVIg (≤1g/kg/3-8week)
Clinically Stable disease for 3 months (according to treating physician opinion).
No treatment withdrawal failure within 1 year
Significant cognitive or communication disorders
Surgery or serious traumatic injury ≤ 6 months
Non ambulant patient
Current participation to a therapeutic trial
Centre Hospitalier Universitaire de Liege
Lead sponsor
SYSNAV
Collaborator
Centre Hospitalier Régional de la Citadelle
Collaborator